《2011NICE卵巢癌的診斷和起始治療》內(nèi)容簡(jiǎn)介：

    These clinical guidelines review a number of clinical questions that involve the detection,diagnosis and initial management of ovarian cancer and which focus on areas ofuncertainty or where there is a wide variation in clinical practice.

    《2011NICE卵巢癌的診斷和起始治療》內(nèi)容預(yù)覽：

    The clinical questions were chosen using a consultative process that involved an array ofstakeholders that included patient groups, representatives from relevant professionalorganisations and the pharmaceutical industry.

    For each chapter of the guideline, the Guideline Development Group （GDG） have madeevidence-based recommendations concerning clinical practice and, where applicable,some recommendations on future research.

    The GDG are pleased that the focus of many of the clinical issues relate to an early stage inthe patient pathway with particular relevance to patients and their families. In particular,identifying the first tests in primary care should help ensure women are directed onto theright clinical pathway in a timely fashion.

    The chair and lead clinician were aided and supported by a diverse and engaged GDGmembership whose complementary skills and perspectives have been instilled in thisguideline.

    點(diǎn)擊下載***：《2011NICE卵巢癌的診斷和起始治療》